Sort
15,842 grants matching “pancreatic cancer”
Repolarizing the Tumor and Metastatic Microenvironments to Treat Patients with Pancreatic Cancer
$516,038Scott Andrew Gerber · University Of Rochester · R01 · FY2021 · CA
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
$516,032Yunyan Jennifer Jennifer Zhang · Duke University · R01 · FY2023 · CA
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
$516,032Chuan-Yuan Li · Duke University · R01 · FY2022 · CA
Role of RABL6A-PP2A in neuroendocrine tumors
$515,955Dawn E Quelle · University Of Iowa · R01 · FY2025 · CA
Interrogation of the Impact of Selection on the Evolution of Human Pancreatic Cancer Precursor Lesions
$515,949Laura Delong Wood · Johns Hopkins University · U01 · FY2024 · CA
Understanding intrinsic resistance to direct KRAS inhibition in colorectal cancers
$515,894John D Gordan · University Of California, San Francisco · R37 · FY2023 · CA
Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis
$515,751Michael B Dwinell · Medical College Of Wisconsin · U01 · FY2017 · CA
Facilitated Education and Testing in BRCA Positive Families
$515,683Marc D Schwartz · Georgetown University · R01 · FY2018 · CA
North American Pancreatitis Study 2 (NAPS2)
$515,637David C Whitcomb · University Of Pittsburgh At Pittsburgh · R01 · FY2006 · DK
Reconstituting human pancreatic cancer development for translational research
$515,614Seung K Kim · Stanford University · R01 · FY2019 · CA
Reconstituting human pancreatic cancer development for translational research
$515,614Seung K Kim · Stanford University · R01 · FY2018 · CA
Reconstituting human pancreatic cancer development for translational research
$515,614Seung K Kim · Stanford University · R01 · FY2017 · CA
Sugar signaling networks detected by high content fluxomics
$515,599Wolf B Frommer · Carnegie Institution Of Washington, D.C. · R01 · FY2008 · DK
Proteostasis Reprogramming in Mutant KRAS-Driven Cancers
$515,378Xi Chen · Baylor College Of Medicine · R01 · FY2023 · CA
The role of collagen and its signaling mechanisms in glioma progression and invasion.
$515,373Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2023 · NS
Engaging immunosuppressive myeloid cells in the TME for the treatment of pancreatic cancer
$515,333Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2024 · CA
Use of BCL-xL Proteolysis targeting chimeras to treat pancreatic cancer
$515,151Guangrong Zheng · University Of Florida · R01 · FY2022 · CA
Use of BCL-xL Proteolysis targeting chimeras to treat pancreatic cancer
$515,151Guangrong Zheng · University Of Florida · R01 · FY2023 · CA
Targeting Lymph Node Dependent Immune Tolerance in Cancer
$514,984Edgar G. Engleman · Stanford University · R01 · FY2024 · CA
Examining the determinants and consequences of supportive care medication use disparities in patients with pancreatic cancer: A sequential mixed-methods approach
$514,964John M Allen · University Of Florida · R01 · FY2024 · MD
K-Ras sumoylation in cell proliferation and transformation
$514,857Wei Dai · New York University School Of Medicine · R01 · FY2017 · CA
Fatty Acylation of Hedgehog and Wnt Proteins
$514,817Marilyn D Resh · Sloan-Kettering Inst Can Research · R01 · FY2017 · GM
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model
$514,346David Charles Lyden · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA
Target discovery and combination therapy in KRAS mutant cancer
$514,251Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Role of Altered Nutrient Metabolism in Pancreatic Cancer
$514,050Nada Y. Kalaany · Boston Children'S Hospital · R01 · FY2023 · CA